Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Greco

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Bone Marrow Transplantation|July 21, 2025
Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patientsAlessandro Criscimanna, Jacques Emmanuel Galimard, Maria Chiara Auriemma, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 19, 2019
CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted PatientsMichele Malagola, Raffaella Greco, Stella Santarone, et al.
Haematologica|September 4, 2025
Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide eraElena Tassi, Giorgio Orofino, Valeria Beretta, et al.
Open Forum Infectious Diseases|December 12, 2017
Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult PatientsNicasio Mancini, Raffaella Greco, Renée Pasciuta, et al.
Bone Marrow Transplantation|June 10, 2022
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemiaLorenzo Lazzari, Aitana Balaguer-Roselló, Juan Montoro, et al.
Bone Marrow Transplantation|August 19, 2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeTobias Alexander, Elisa Roldan, Nicoletta Del Papa, et al.
Frontiers in Immunology|June 8, 2023
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemiaChiara Oltolini, Andrea Acerbis, Giorgio Orofino, et al.
Bone Marrow Transplantation|September 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working partyRaffaella Greco, Riccardo Saccardi, Marta Ponzano, et al.
Neurology|January 21, 2021
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple SclerosisGiacomo Boffa, Luca Massacesi, Matilde Inglese, et al.
Blood Advances|April 17, 2023
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipientsMaddalena Noviello, Francesca Lorentino, Elisabetta Xue, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|July 21, 2025
Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patientsAlessandro Criscimanna, Jacques Emmanuel Galimard, Maria Chiara Auriemma, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 19, 2019
CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted PatientsMichele Malagola, Raffaella Greco, Stella Santarone, et al.
Haematologica|September 4, 2025
Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide eraElena Tassi, Giorgio Orofino, Valeria Beretta, et al.
Open Forum Infectious Diseases|December 12, 2017
Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult PatientsNicasio Mancini, Raffaella Greco, Renée Pasciuta, et al.
Bone Marrow Transplantation|June 10, 2022
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemiaLorenzo Lazzari, Aitana Balaguer-Roselló, Juan Montoro, et al.
Bone Marrow Transplantation|August 19, 2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeTobias Alexander, Elisa Roldan, Nicoletta Del Papa, et al.
Frontiers in Immunology|June 8, 2023
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemiaChiara Oltolini, Andrea Acerbis, Giorgio Orofino, et al.
Bone Marrow Transplantation|September 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working partyRaffaella Greco, Riccardo Saccardi, Marta Ponzano, et al.
Neurology|January 21, 2021
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple SclerosisGiacomo Boffa, Luca Massacesi, Matilde Inglese, et al.
Blood Advances|April 17, 2023
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipientsMaddalena Noviello, Francesca Lorentino, Elisabetta Xue, et al.
Pageof 19